TrialEuropean journal of pediatrics2010

Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months.

Markus Knuf et al.PubMed ↗Publisher ↗

No numbers read from the abstract.